Non-HIV
Showing 1 - 25 of >10,000
Pneumocystis Jirovecii Pneumonia Trial in Beijing (Radiomic model)
Active, not recruiting
- Pneumocystis Jirovecii Pneumonia
- Radiomic model
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Jan 25, 2023
Blood and Reproductive Fluids in HIV-Infected and
Recruiting
- HIV
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Pneumocystis Jirovecii Pneumonia in Non-HIV-infected
Active, not recruiting
- Pneumocystis Jirovecii Infection
-
Vandoeuvre Les Nancy, Lorraine, FranceUniversité de Lorraine, CHRU Nancy and APEMAC
Jul 12, 2022
HIV, Non-Alcoholic Fatty Liver Disease, Metabolic-Associated Steatotic Liver Disease Trial in Nashville (Prebiotic, Probiotic)
Not yet recruiting
- HIV
- +2 more
- Prebiotic
- Probiotic
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 30, 2023
HIV, Non-HIV, Vagus Nerve Dysfunction Trial in New York (Pyridostigmine, Placebos, non-invasive vagal nerve stimulation)
Recruiting
- HIV
- +2 more
- Pyridostigmine
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Apr 12, 2022
Incidence of Opportunistic Fungal Infections
Not yet recruiting
- Pneumocystis Jirovecii Infection
- +4 more
- (no location specified)
Jan 30, 2023
RZV Vaccine (Shingrix ®) Trial in France, Switzerland (Recombinant Zoster Vaccine)
Not yet recruiting
- RZV Vaccine (Shingrix ®)
- Recombinant Zoster Vaccine
-
Bordeaux, France
- +7 more
Oct 27, 2022
People Living With HIV Treated With CD19-directed CAR T Cell
Active, not recruiting
- Leukemia
- +9 more
-
Philadelphia, PennsylvaniaPennsylvania Hospital
Mar 29, 2023
AIDS Virus, Disorder of Immune Reconstitution Trial in Jinan (normal saline, Mesenchymal stem cells)
Recruiting
- AIDS Virus
- Disorder of Immune Reconstitution
- normal saline
- Mesenchymal stem cells
-
Jinan, Shandong, ChinaShandong Public Health Clinical Center
May 14, 2023
Leukapheresis to Obtain Plasma or Lymphocytes for Studies of
Recruiting
- HIV
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2023
HIV-infected Non-malarial Febrile Illnesses Using Metagenomic
Recruiting
- HIV Infection
-
Mulago, UgandaBaylor College of Medicine Children's Foundation-Uganda
Oct 4, 2022
Rates of Integration of AIDS Indicator Conditions Into Hospital
Recruiting
- HIV Infections
- Non-interventional
-
Ankara, TurkeyAnkara Eğitim ve Araştırma Hastanesi
Dec 23, 2022
HIV Trial in Boston (TRUVADA + raltegravir)
Completed
- HIV Infections
- TRUVADA + Raltegravir
-
Boston, MassachusettsFenway Community Health
Oct 4, 2022
HIV-1-infection Trial (Fostemsavir 600 MG [Rukobia])
Recruiting
- HIV-1-infection
- Fostemsavir 600 MG [Rukobia]
-
Orlando, FloridaOrlando Immunology Center
Sep 20, 2022
French CAC-HIV Cohort Study
Completed
- Coronary Artery Calcification
- HIV Infections
- Computed tomography coronary artery calcium (CAC) score (part of routine workup)
- (no location specified)
Oct 24, 2022
NAFLD, NASH - Nonalcoholic Steatohepatitis, HIV Trial in Indianapolis, Boston (Vitamin E, Placebos)
Active, not recruiting
- NAFLD
- +2 more
- Vitamin E
- Placebos
-
Indianapolis, Indiana
- +1 more
Feb 1, 2023
Kaposi Sarcoma, HIV-1-infection Trial (Pegylated liposomal doxorubicin, Paclitaxel)
Not yet recruiting
- Kaposi Sarcoma
- HIV-1-infection
- Pegylated liposomal doxorubicin
- Paclitaxel
- (no location specified)
Jan 20, 2023
Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)
Recruiting
- Diffuse Large Cell Lymphoma
- +4 more
- Vincristine
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
HIV, Bariatric Surgery Candidate Trial (bariatric surgery)
Not yet recruiting
- HIV Infections
- Bariatric Surgery Candidate
- bariatric surgery
- (no location specified)
Sep 9, 2022
Tool to Describe HIV-Related Cancer Burden and Patient
Not yet recruiting
- HIV-Associated Malignant Neoplasm
- +7 more
- Non-Interventional
- Non-Interventional Follow-up
- (no location specified)
Aug 18, 2022
Hepatitis C Treatment Study in Myanmar
Withdrawn
- Hepatitis C
- Sofosbuvir 400 mg
-
Yangon, MyanmarMedical Action Myanmar
Dec 3, 2021
HIV/AIDS Trial in Masaka (Intensive Adherence Counselling (IAC))
Not yet recruiting
- HIV/AIDS
- Intensive Adherence Counselling (IAC)
-
Masaka, UgandaKalisizo Hospital
Aug 22, 2022
NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)
Not yet recruiting
- NSCLC Stage IV
- +4 more
- Nivolumab and Ipilimumab
-
Verona, Veneto/Verona, ItalyCentro Ricerche Cliniche
Oct 26, 2022